Stock Performance Overview
The stock declined by 5.88% on 16 Mar 2026, significantly underperforming the Sensex, which gained 1.14% on the same day. Over the past week, Deccan Health Care Ltd fell 3.38%, compared to a 2.78% decline in the Sensex. The one-month performance shows a sharper drop of 13.61%, while the Sensex fell 9.44% in the same period. The three-month trend is more pronounced, with the stock losing 24.76% against the Sensex’s 10.94% decline.
Year-to-date, the stock has dropped 18.97%, underperforming the Sensex’s 11.51% fall. Over the last year, Deccan Health Care Ltd has delivered a negative return of 38.81%, while the Sensex posted a positive 2.15%. The three-year and five-year performances are particularly stark, with losses of 59.02% and 59.80% respectively, contrasting sharply with the Sensex’s gains of 30.85% and 49.74% over the same periods. The stock’s 10-year return stands at 0.00%, while the Sensex surged 205.53%.
Technical Indicators and Market Positioning
Deccan Health Care Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downtrend. The stock’s underperformance extends to its sector, lagging the Healthcare Services sector by 2.57% on the latest trading day.
Fundamental Assessment and Ratings
The company’s Mojo Score stands at 29.0, with a Mojo Grade of Strong Sell as of 23 Feb 2026, downgraded from Sell. This rating reflects weak long-term fundamental strength, underscored by an average Return on Equity (ROE) of just 1.43%. The micro-cap classification further highlights the stock’s limited market capitalisation and liquidity.
Deccan Health Care Ltd has consistently underperformed the BSE500 benchmark over the last three years, generating negative returns in each of the last three annual periods. This persistent underperformance has contributed to the stock’s deteriorating market standing and valuation pressures.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Financial Metrics and Operational Highlights
Despite the stock’s weak price performance, Deccan Health Care Ltd has reported positive results for four consecutive quarters. The company’s inventory turnover ratio for the half year stands at 1.84 times, indicating efficient inventory management relative to its scale. Quarterly PBDIT reached a high of ₹1.73 crore, while the operating profit to net sales ratio peaked at 9.95%, reflecting operational profitability within its revenue base.
Valuation metrics show the stock trading at an attractive price-to-book value of 0.3, suggesting a discount relative to its peers’ historical averages. The company’s ROE of 1.3% remains modest but is accompanied by a PEG ratio of 0.2, indicating low price-to-earnings growth expectations.
Market Capitalisation and Sector Context
Classified as a micro-cap, Deccan Health Care Ltd operates within the Healthcare Services sector, which has generally outperformed the stock. The company’s market cap grade reflects its relatively small size and the challenges it faces in scaling operations or attracting broader market participation.
Considering Deccan Health Care Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Summary of Challenges and Market Standing
Deccan Health Care Ltd’s stock has experienced a prolonged period of decline, with returns significantly lagging benchmark indices and sector peers. The company’s fundamental indicators, including ROE and market capitalisation, remain subdued. While recent quarters have shown positive earnings trends and operational profitability ratios, these have not translated into improved market performance or investor confidence.
The stock’s position near its 52-week low and trading below all major moving averages underscores the prevailing bearish sentiment. The downgrade to a Strong Sell rating by MarketsMOJO further reflects the cautious stance on the stock’s outlook based on current fundamentals and price action.
Conclusion
Deccan Health Care Ltd’s all-time low closing price marks a significant milestone in its recent market trajectory. The combination of weak long-term returns, micro-cap status, and persistent underperformance against benchmarks highlights the severity of the situation. Despite some positive quarterly financial indicators, the stock remains under pressure, reflecting the broader challenges faced by the company within the Healthcare Services sector.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
